Cite

HARVARD Citation

    Farabegoli, F. et al. (2017). EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion. Bioscience reports. 37 (3), p. . [Online]. 
  
Back to record